Integrated Diagnostics Holdings ( (GB:IDHC) ) has issued an announcement.
Integrated Diagnostics Holdings (IDH) announced it will release its audited financial results for the year ending 31 December 2024 on 17 April 2025. The company will host an analyst and investor call on the same day to discuss the results. This announcement is significant as it reflects the company’s ongoing transparency and engagement with stakeholders, potentially impacting its market positioning and investor relations.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent provider of diagnostic services in the Middle East and Africa, offering a wide range of clinical pathology and radiology tests across Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. With over 40 years of experience, IDH operates through brands such as Al Borg, Al Mokhtabar, and Biolab, among others. The company is known for its quality and safety standards, serving over 8.5 million patients and conducting more than 36.1 million tests in 2023. IDH is listed on the London Stock Exchange and aims to expand through a scalable business model and strategic acquisitions in emerging markets.
YTD Price Performance: -13.64%
Average Trading Volume: 210,007
Technical Sentiment Signal: Strong Buy
Current Market Cap: $220.9M
Find detailed analytics on IDHC stock on TipRanks’ Stock Analysis page.